Winner Medical Co., Ltd. (SHE:300888)
China
· Delayed Price · Currency is CNY 39.88
+0.06 (0.15%)
Jun 27, 2025, 3:04 PM CST
Winner Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 25,145 | 24,504 | 21,889 | 30,011 | 35,164 | 70,798 | Upgrade
|
| Market Cap Growth | 34.08% | 11.95% | -27.06% | -14.65% | -50.33% | - | Upgrade
|
| Enterprise Value | 24,866 | 22,177 | 16,936 | 25,711 | 28,699 | 63,672 | Upgrade
|
| Last Close Price | 43.18 | 41.86 | 35.92 | 47.68 | 54.15 | 107.44 | Upgrade
|
| PE Ratio | 32.99 | 35.24 | 37.71 | 18.18 | 28.37 | 18.58 | Upgrade
|
| Forward PE | 23.64 | 26.38 | 11.53 | 18.04 | 17.13 | 28.43 | Upgrade
|
| PS Ratio | 2.60 | 2.73 | 2.67 | 2.64 | 4.38 | 5.65 | Upgrade
|
| PB Ratio | 2.07 | 2.06 | 1.81 | 2.46 | 3.29 | 6.76 | Upgrade
|
| P/TBV Ratio | 2.77 | 2.78 | 2.26 | 3.11 | 3.38 | 6.91 | Upgrade
|
| P/FCF Ratio | 55.66 | 67.16 | 70.55 | 16.82 | 273.82 | 16.88 | Upgrade
|
| P/OCF Ratio | 20.97 | 19.36 | 20.59 | 10.06 | 40.34 | 14.85 | Upgrade
|
| EV/Sales Ratio | 2.57 | 2.47 | 2.07 | 2.27 | 3.57 | 5.08 | Upgrade
|
| EV/EBITDA Ratio | 16.17 | 19.44 | 17.06 | 12.55 | 22.43 | 12.95 | Upgrade
|
| EV/EBIT Ratio | 25.96 | 28.04 | 25.01 | 14.43 | 25.79 | 13.38 | Upgrade
|
| EV/FCF Ratio | 55.05 | 60.78 | 54.59 | 14.41 | 223.48 | 15.18 | Upgrade
|
| Debt / Equity Ratio | 0.21 | 0.24 | 0.18 | 0.23 | 0.06 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.64 | 2.13 | 1.79 | 1.25 | 0.40 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 5.58 | 7.95 | 7.02 | 1.59 | 4.66 | 0.04 | Upgrade
|
| Asset Turnover | 0.56 | 0.51 | 0.46 | 0.72 | 0.61 | 1.43 | Upgrade
|
| Inventory Turnover | 3.06 | 2.88 | 2.94 | 4.02 | 2.93 | 4.72 | Upgrade
|
| Quick Ratio | 1.11 | 1.13 | 2.02 | 1.88 | 4.13 | 3.96 | Upgrade
|
| Current Ratio | 1.70 | 1.53 | 2.47 | 2.21 | 4.99 | 4.53 | Upgrade
|
| Return on Equity (ROE) | 6.66% | 6.18% | 5.17% | 14.63% | 11.70% | 56.08% | Upgrade
|
| Return on Assets (ROA) | 3.49% | 2.78% | 2.39% | 7.07% | 5.29% | 33.93% | Upgrade
|
| Return on Capital (ROIC) | 4.17% | 3.40% | 2.89% | 8.46% | 6.35% | 42.37% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.20% | 6.00% | 5.30% | 14.00% | 9.90% | 45.00% | Upgrade
|
| Earnings Yield | 3.03% | 2.84% | 2.65% | 5.50% | 3.52% | 5.38% | Upgrade
|
| FCF Yield | 1.80% | 1.49% | 1.42% | 5.95% | 0.36% | 5.92% | Upgrade
|
| Dividend Yield | 1.14% | 1.55% | 1.39% | 2.85% | 1.66% | 1.68% | Upgrade
|
| Payout Ratio | 61.98% | 59.34% | 141.56% | 24.29% | 61.98% | 2.69% | Upgrade
|
| Buyback Yield / Dilution | 1.75% | 1.33% | -0.10% | 0.77% | -9.42% | -3.31% | Upgrade
|
| Total Shareholder Return | 3.01% | 2.89% | 1.29% | 3.61% | -7.76% | -1.63% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.